GVG and Addiction
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
GVG, known as vigabatrin in the 70 countries where it is used for treating epilepsy, has a unique mechanism of action. Dr. Stephen Dewey of BHL explains to host Dr. Leslie Lundt his research into this compound and how it potentially could change the course of addictive disorders.
Overview
GVG, known as vigabatrin in the 70 countries where it is used for treating epilepsy, has a unique mechanism of action. Dr. Stephen Dewey of BHL explains to host Dr. Leslie Lundt his research into this compound and how it potentially could change the course of addictive disorders.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Updates From the 7th World Symposium Task Force
Diagnosis and Management of Metastatic PDAC
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?